Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update

被引：0
|
作者：
Mooney, Kelly [1 ]
Stehr, Henning [1 ]
Kunder, Christian [2 ]
Zehnder, James [2 ]
Allison, Kimberly [2 ]
Lin, Chieh-Yu [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
216
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
    Plata, Adriana
    Torres, Maria Mercedes
    Lopez, Rocio
    Andrade, Rafael E.
    COLOMBIA MEDICA, 2013, 44 (02): : 108 - 114
  • [22] Comparison between immunohistochemistry and chromogenic in situ hybridization in assessing HER-2 status in breast cancer
    Todorovic-Rakovic, N
    Jovanovic, D
    Neskovic-Konstantinovic, Z
    Nikolic-Vukosavljevic, D
    PATHOLOGY INTERNATIONAL, 2005, 55 (06) : 318 - 323
  • [23] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [24] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [25] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [26] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Stocker, Albina
    Trojan, Andreas
    Elfgen, Constanze
    Hilbers, Marie-Louis
    Moskovszky, Linda
    Varga, Zsuzsanna
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (02) : 311 - 319
  • [27] Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer
    Albina Stocker
    Andreas Trojan
    Constanze Elfgen
    Marie-Louis Hilbers
    Linda Moskovszky
    Zsuzsanna Varga
    Breast Cancer Research and Treatment, 2020, 183 : 311 - 319
  • [28] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Cornelia Hauser-kronberger
    Nadia Dandachi
    Journal of Molecular Histology, 2004, 35 (6) : 647 - 653
  • [29] Comparison of chromogenic in situ hybridization with other methodologies for HER2 status assesment in breast cancer
    Hauser-Kronberger, C
    Dandachi, N
    JOURNAL OF MOLECULAR HISTOLOGY, 2004, 35 (06) : 647 - 653
  • [30] Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma
    Febres-Aldana, Christopher A.
    Chang, Jason C.
    Jungbluth, Achim A.
    Adusumilli, Prasad S.
    Bodd, Francis M.
    Frosina, Denise
    Geronimo, Jerica A.
    Hernandez, Enmily
    Irawan, Helen
    Offin, Michael D.
    Rekhtman, Natasha
    Travis, William D.
    Vanderbilt, Chad
    Zauderer, Marjorie G.
    Zhang, Yanming
    Ladanyi, Marc
    Yang, Soo-Ryum
    Sauter, Jennifer L.
    MODERN PATHOLOGY, 2024, 37 (03)
12345